Machine learning-derived clinical phenotypes of ascites in cirrhosis: A multi-center latent class analysis with external validation [0.03%]
基于机器学习的肝硬化腹水临床表型：多中心潜在类别分析及外部验证
Giuseppe Cullaro,Jennifer C Lai,Taryn Liu et al.
Giuseppe Cullaro et al.
Background: Ascites development in cirrhosis reduces five-year survival from 80% to 30%, yet substantial heterogeneity exists among patients with comparable ascites severity. ...
VITRO score dynamics after liver transplantation predict portal-hypertensive events and post-transplant mortality [0.03%]
肝移植后的VITRO评分变化可预测门脉高压事件和移植后死亡率
Nina Dominik,Petra Dinjar Kujundzic,Felix Kristandl et al.
Nina Dominik et al.
Background aims: Portal hypertension (PH) after liver transplantation (LT) is rare but associated with complications and mortality. The VITRO score - combining von Willebrand Factor antigen (vWF) divided by platelet count...
GLP-1 receptor agonists after liver transplant: Early reassurance, unanswered questions [0.03%]
肝脏移植后的GLP-1受体激动剂：初步安慰，仍存疑问
Somaya Albhaisi,Jonathan Spagnoli,Pratima Sharma
Somaya Albhaisi
Jesse D Schold,Susana Arrigain,Sumit Mohan et al.
Jesse D Schold et al.
Changes in organ allocation, technology and regulatory policy have led to significant increases in deceased donor liver offers for transplantation. Expansion of potential donors is associated with inefficiencies including increased liver no...
Letter to the Editor: Benchmarking a robust mitochondrial biomarker against a moving target [0.03%]
致编辑信函：针对一个移动目标对稳健的线粒体生物标志物进行基准测试
Keyue Sun,Khaled Ali,Geofia S Crasta et al.
Keyue Sun et al.
Retraction: Targeted Immunomodulation in Post-Transplant Sepsis: Mechanistic and Clinical Insights from a Phase-Based Approach Integrating IgM-Enriched IVIG and Hemoadsorption [0.03%]
撤稿：基于分期方法整合IgM富集型IVIG和血液吸附的移植后脓毒症靶向免疫调节：机制和临床启示
Vanja Silić,Ivan Romić,Goran Pavlek et al.
Vanja Silić et al.
Reply: Benchmarking a robust mitochondrial biomarker against a moving target [0.03%]
致：稳健的线粒体生物标志物在移动目标中的基准测试回复：
Vincent E de Meijer,Sabrina Stimmeder,Janina Eden et al.
Vincent E de Meijer et al.
The impact of supervised aerobic and resistance exercise prehabilitation on frailty and recovery after living donor liver transplantation: Open-label randomized trial [0.03%]
有监督有氧运动和阻力锻炼对肝移植患者衰弱及术后恢复的影响：开放随机对照试验
Sambhav Gupta,Nihar Mohapatra,Nilesh Sadashiv Patil et al.
Sambhav Gupta et al.
Background: Frailty adversely affects post-transplant outcomes in chronic liver disease (CLD). This study evaluated the feasibility and the impact of preoperative supervised aerobic and resistance exercises (SARE) on frai...
Staged percutaneous coronary intervention and simultaneous coronary artery bypass grafting in living donor liver transplantation: A single-center retrospective cohort study [0.03%]
分阶段经皮冠状动脉介入治疗与同期冠状动脉旁路移植肝移植的单中心回顾性队列研究
Tumay Uludag Yanaral,Busra Oner Akbalik,Hande Gungor Danisan et al.
Tumay Uludag Yanaral et al.
Coronary artery disease in living donor liver transplantation (LDLT) candidates requires revascularization strategies balancing cardiac risk against end-stage liver disease complexity. Data on revascularization outcomes in this setting rema...
Liver transplant center prioritization of patients with low-dropout-risk hepatocellular carcinoma is associated with worse waitlist outcomes for remaining candidates [0.03%]
对低脱落风险肝细胞癌患者进行肝脏移植中心优先分配会影响其余候选者的等待名单结果
Dominic Amara,Andrew Melehy,Carolyn Smullin et al.
Dominic Amara et al.
The survival benefit of liver transplantation (LT) for hepatocellular carcinoma (HCC) varies by waitlist dropout risk, yet allocation policy applies uniform prioritization, and center practices remain poorly characterized. We performed a re...